Advertisement
Screener

UTAH MEDICAL PRODUCTS, INC. (UTMD) Cash Flow Breakdown

UTAH MEDICAL PRODUCTS, INC. Cash Flow Breakdown

Cash flow breakdown shows where UTAH MEDICAL PRODUCTS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $14.69M came in.
  • Fiscal year ended 2025-12-31: from investing, $371.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $12.34M went out.
  • Fiscal year ended 2025-12-31: change in cash, $2.78M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDividendsNew shares soldNot split outChange in cash
2025-12-31$14.69M-$371.00K-$8.36M-$3.98M$0.00$2.78M
2024-12-31$14.83M-$208.00K-$19.97M-$4.26M$390.00K-$9.89M
2023-12-31$22.28M-$639.00K$0.00-$4.28M$117.00K$17.82M
2022-12-31$21.15M-$818.00K-$2.50M-$3.16M$174.00K$14.08M
2021-12-31$21.20M-$552.00K$0.00-$11.46M$560.00K$9.38M
2020-12-31$20.14M-$860.00K-$6.98M-$4.12M$358.00K$8.80M
2019-12-31$17.06M-$21.54M-$398.00K-$4.11M$283.00K-$8.32M
2018-12-31$16.83M$534.00K-$1.21M-$4.03M$454.00K$11.24M
2017-12-31$16.91M-$1.60M$0.00-$2.96M$302.00K$13.58M
2016-12-31$14.53M-$3.30M-$3.92M$376.00K-$2.80M*$3.02M
2015-12-31$13.80M-$246.00K-$3.85M$343.00K-$5.39M*$4.00M
2014-12-31$15.39M-$1.13M-$3.77M$491.00K-$4.99M*$4.88M
2013-12-31$12.31M-$344.00K-$3.67M$787.00K-$3.71M*$5.52M
2012-12-31$13.56M-$208.00K-$3.56M$1.80M-$9.42M*$2.34M
2011-12-31$11.37M-$26.68M-$3.43M$485.00K$21.03M*$2.72M
2010-12-31$7.16M$2.71M-$6.03M$425.00K*$3.41M
2009-12-31$7.23M-$3.16M-$3.34M$132.00K*$313.00K

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDividendsNew shares soldNot split outChange in cash
2026-06-30$1.38M*-$134.00K*-$78.00K*-$987.00K*
2026-03-31$3.11M-$130.00K-$128.00K-$989.00K$1.65M
2025-12-31$3.48M*-$109.00K*-$994.00K*-$977.00K*$0.00*
2025-09-30$3.88M*-$27.00K*-$653.00K*-$988.00K*$0.00*
2025-06-30$2.87M*-$51.00K*-$3.49M*-$1.00M*$0.00*
2025-03-31$4.46M-$184.00K-$3.22M-$1.02M$0.00$349.00K
2024-12-31$2.94M*-$9.00K*-$6.71M*-$1.04M*$0.00*
2024-09-30$3.86M*-$89.00K*-$3.87M*-$1.05M*$0.00*
2024-06-30$2.76M*-$115.00K*-$6.40M*-$1.08M*$294.00K*
2024-03-31$5.28M$5.00K-$2.99M-$1.09M$96.00K$940.00K
2023-12-31$5.33M*-$90.00K*$0.00*-$1.07M*$0.00*
2023-09-30$5.12M*-$186.00K*$0.00*-$1.07M*$36.00K*
2023-06-30$4.91M*-$320.00K*$0.00*-$1.07M*$60.00K*
2023-03-31$6.92M-$43.00K$0.00-$1.07M$21.00K$5.86M
2022-12-31$5.68M*-$38.00K*$0.00*-$1.05M*$131.00K*
2022-09-30$5.59M*-$321.00K*$0.00*-$1.05M*$20.00K*
2022-06-30$4.83M*-$222.00K*-$1.06M*$4.00K*-$2.50M*
2022-03-31$5.05M-$237.00K$0.00$19.00K$4.90M
2021-12-31$4.99M*-$253.00K*$0.00*-$8.35M*$279.00K*
2021-09-30$5.99M*-$77.00K*$0.00*-$1.04M*$189.00K*
2021-06-30$4.69M*-$212.00K*$0.00*-$1.04M*$3.00K*
2021-03-31$5.53M-$10.00K$0.00-$1.04M$89.00K$4.44M
2020-12-31$5.78M*-$54.00K*$1.00K*-$1.02M*$76.00K*
2020-09-30$5.01M*-$95.00K*-$551.00K*-$1.02M*$203.00K*
2020-06-30$3.68M*-$257.00K*$0.00*-$1.03M*$31.00K*
2020-03-31$5.67M-$454.00K-$6.43M-$1.04M$48.00K-$3.17M
2019-12-31$5.64M*-$288.00K*$0.00*-$1.03M*$60.00K*$5.39M*
2019-09-30$6.37M*-$122.00K*$0.00*-$1.03M*$52.00K*$4.51M*
2019-06-30$1.68M*-$118.00K*-$398.00K*-$1.03M*$74.00K*$215.00K*
2019-03-31$3.36M-$21.01M$0.00-$1.03M$97.00K-$18.45M
2018-12-31$4.48M*-$147.00K*-$1.01M*$18.00K*-$1.21M*$1.76M*
2018-09-30$4.60M*-$54.00K*-$1.01M*$89.00K*$3.48M*
2018-06-30$3.98M*$908.00K*-$1.01M*$200.00K*$3.02M*
2018-03-31$3.77M-$173.00K-$1.00M$147.00K$2.98M
2017-12-31$4.58M*-$1.42M*-$986.00K*$78.00K*$2.44M*
2017-09-30$4.58M*-$60.00K*-$985.00K*$56.00K*$3.70M*
2017-06-30$3.44M*-$49.00K*-$984.00K*$115.00K*$3.06M*
2017-03-31$4.31M-$65.00K$0.00$53.00K$4.38M
2016-12-31$3.38M*-$3.06M*-$1.96M*$70.00K*-$2.80M*-$5.26M*
2016-09-30$3.38M*-$147.00K*-$978.00K*$49.00K*$2.16M*
2016-06-30$3.61M*-$47.00K*-$976.00K*$109.00K*$1.88M*
2016-03-31$4.15M-$52.00K$0.00$148.00K$4.24M
2015-12-31$3.91M*-$40.00K*-$1.93M*$45.00K*$1.66M*
2015-09-30$4.16M*-$90.00K*-$957.00K*$53.00K*$2.45M*
2015-06-30$3.49M*-$46.00K*-$957.00K*$173.00K*$3.07M*
2015-03-31$2.24M-$70.00K$0.00$72.00K-$4.76M*-$3.17M
2014-12-31$4.53M*-$179.00K*-$1.89M*$130.00K*-$1.06M*$1.03M*
2014-09-30$5.10M*-$117.00K*-$936.00K*$90.00K*-$1.20M*$2.31M*
2014-06-30$3.84M*-$178.00K*-$938.00K*$27.00K*-$1.79M*$901.00K*
2014-03-31$1.92M-$658.00K$0.00$244.00K-$938.00K*$643.00K
2013-12-31$3.25M*-$117.00K*-$1.85M*$140.00K*-$954.00K*$525.00K*
2013-09-30$4.02M*-$111.00K*-$913.00K*$157.00K*-$933.00K*$2.48M*
2013-06-30$2.32M*-$64.00K*$150.00K*-$1.85M*$515.00K*
2013-03-31$2.72M-$52.00K$340.00K-$884.00K*$2.00M
2012-12-31$3.06M*-$11.00K*-$1.79M*$618.00K*-$2.34M*-$417.00K*
2012-09-30$3.96M*-$63.00K*-$884.00K*$207.00K*-$1.95M*$1.38M*
2012-06-30$3.10M*-$72.00K*$393.00K*-$3.59M*-$246.00K*
2012-03-31$3.43M-$62.00K$585.00K-$2.41M*$1.62M
2011-12-31$3.51M*-$52.00K*-$1.73M*$43.00K*-$2.26M*-$505.00K*
2011-09-30$3.41M*-$39.00K*-$854.00K*$67.00K*-$1.75M*$773.00K*
2011-06-30$1.68M*-$142.00K*$339.00K*-$2.63M*-$741.00K*
2011-03-31$2.76M-$26.45M$36.00K$26.81M*$3.19M
2010-12-31$1.67M*$2.69M*-$7.74M*$45.00K*$3.31M*-$33.00K*
2010-09-30$1.82M*-$154.00K*$854.00K*$5.00K*-$2.13M*$419.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
PRO DEX INC (PDEX)United States$0.234B13.64
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
Neuronetics, Inc. (STIM)United States$0.216B-3.25
Profound Medical Corp. (PROF)$0.206B-7.37
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Mobia Medical, Inc. (MOBI)United States$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32